HDAC6, which is overexpressed in clinical GBM tumors [22], TMZ-resistant GBM cells and GBM stem-like tumorspheres [23], affects the expression of cell-cycle-related genes and cancer stemness-related genes through regulating acetylation levels of Sp1 transcription factor [23, 24]. Here, HDAC6 is linked to glioblastoma.